New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2014
08:03 EDTANIPANI Pharmaceuticals enters development agreement with Sterling Pharmaceutical
ANI Pharmaceuticals announced that it has entered into a fee-for-service development agreement for a generic drug product with Sterling Pharmaceutical Services. The product will be developed by Sterling and transferred into ANI's facilities for commercial manufacture and marketing. The current annual market for this product is $60M, according to IMS Health.
News For ANIP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 1, 2016
08:13 EDTANIPANI acquires exclusive rights to distribute three generics from H2 Pharma
ANI Pharmaceuticals announced that it has acquired the exclusive rights to distribute 1% and 2.5% hydrocortisone cream for rectal use and the exclusive rights to distribute the authorized generic of Lipofen from H2-Pharma, LLC for $10M. In addition, ANI also acquired an early stage development project for an undisclosed generic injectable drug product.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use